SXTC

China SXT Pharmaceuticals Inc. Class A Ordinary Shares (SXTC)

Stock · NASDAQ · Health Care

$0.0633as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

SXTC Featured Among Friday's Top Health Care Movers. On Friday, SXTC was listed among the top gainers and among the 12 health‑care stocks that moved during the intraday session. The stock also appeared in the gap‑up/gap‑down list, indicating a notable opening move. These movements suggest increased short‑term interest in the company. The price remains above its 15‑touch support level of $2.01.

Active signals

High Beta36.4%
200 SMA Touch0.0%
Resistance level
$1.58
Industry
Biotechnology: Pharmaceutical Preparations

What SXTC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown24-13.8%29%
Bollinger Band Breakout17-16.0%24%
Volume Spike11-14.0%36%
Any 20-session window (baseline)-10.3%30%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SXTC

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
56

Fundamentals

1-day range
$0.0621$0.081
Market cap
$2.06M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-7.95
Dividend yield
—
Beta
1.77
Avg. volume
10.47M
52-week range
$0.0619$83,758

China SXT Pharmaceuticals Inc. Class A Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • SXTC
    China SXT Pharmaceuticals Inc. Class A Ordinary Shares
    $0.065
    ▼ 5.80%
    Market cap $2.06MP/E —
    $0.0619$83,758
  • BFRGW
    Bullfrog AI Holdings Inc. Warrants
    $0.13
    ▲ 25.85%
    Market cap $2.04MP/E —
    $0.0751$0.6488
  • AZTR
    Azitra Inc Common Stock
    $0.072
    ▲ 0.00%
    Market cap $2.18MP/E 6.22
    $0.0518$1.09
  • GNPX
    Genprex Inc. Common Stock
    $2.11
    ▼ 7.86%
    Market cap $2.24MP/E —
    $2.53$1,210
  • PPBT
    Purple Biotech Ltd. American Depositary Shares
    $1.14
    ▼ 7.32%
    Market cap $2.29MP/E —
    $1$2.2
  • CMND
    Clearmind Medicine Inc. Common Shares
    $6.26
    ▼ 2.49%
    Market cap $1.78MP/E —
    $5.25$3,840
  • DCOY
    Decoy Therapeutics Inc. Common Stock
    $1.17
    ▼ 4.88%
    Market cap $2.40MP/E —
    $2.01$55.92

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.